EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
December 31, 2019 0.0425
September 30, 2019 0.1869
June 30, 2019 0.3002
March 31, 2019 0.0737
December 31, 2018 0.0673
September 30, 2018 0.1895
June 30, 2018 0.2788
March 31, 2018 0.0665
December 31, 2017 0.0488
September 30, 2017 0.1332
June 30, 2017 0.1674
March 31, 2017 0.0537
December 31, 2016 0.056
September 30, 2016 0.1427
June 30, 2016 0.1628
March 31, 2016 0.0556
December 31, 2015 0.0611
September 30, 2015 0.1143
June 30, 2015 0.3936
March 31, 2015 0.045
December 31, 2014 0.0649
September 30, 2014 0.0975
June 30, 2014 0.2171
March 31, 2014 0.0441
December 31, 2013 0.0872
Date Value
September 30, 2013 0.0804
June 30, 2013 0.193
March 31, 2013 0.0286
December 31, 2012 0.1264
September 30, 2012 0.075
June 30, 2012 0.1618
March 31, 2012 0.0266
December 31, 2011 0.0537
September 30, 2011 0.0282
June 30, 2011 0.1752
March 31, 2011 0.0235
December 31, 2010 0.0977
September 30, 2010 0.1012
June 30, 2010 0.1385
March 31, 2010 0.024
December 31, 2009 -0.0469
September 30, 2009 0.0708
June 30, 2009 0.1253
March 31, 2009 0.0276
December 31, 2008 0.0122
September 30, 2008 0.0696
June 30, 2008 0.1497
March 31, 2008 0.0284
December 31, 2007 0.2282
September 30, 2007 0.0803

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 0.9849
ANI Pharmaceuticals, Inc. 1.052
Corcept Therapeutics, Inc. 0.356
Veru, Inc. -0.3032
Avadel Pharmaceuticals Plc 0.0002

EPS Diluted (Quarterly) Related Metrics